Controlled substance found in herbal supplement prompts recall

B-Lipo Capsules are marketed as a natural supplement for weight loss.

Hp 28748 Ucm427659

Bethel Nutritional Consulting is recalling one lot of their B-Lipo Capsules after the FDA found a sample collected and tested by the agency contained Lorcaserin, a controlled substance used for weight loss.

According to the FDA, adverse health consequences associated with taking Lorcaserin range from difficulty thinking, hallucinations, and feeling of intense excitement to changes in blood sugar and heart rate. More serious adverse events, which may be life-threatening, include damage to the heart valve, or serotonin syndrome particularly if Lipo-B is taken with other medications that work similarly.

The recalled capsules are burgundy and white, packaged in white plastic bottles containing 30 capsules per bottle, and labeled with Lot # 20213 EXP DATE 12/22/2016, and bar code 160126 417509.

The product was sold directly to individual customers in their New York City sales, office and to consumers online at www.bethel30.com.

The company has discontinued distribution of this product, according to the FDA.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?